OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
4928$4375.0059

Noevir Holdings Co Ltd

Personal ProductsVerified

The company maintains a strong liquidity position, with a current ratio of 4.96 and cash and equivalents amounting to ¥26.93 billion, which is significantly higher than the typical liquidity needs for a firm in the personal products industry. The debt-to-equity ratio is 0.01, indicating a conservative capital structure with minimal reliance on debt financing. This low leverage supports financial stability and flexibility in capital allocation. Profitability metrics show a return on equity (ROE) of 14.93% and a return on assets (ROA) of 10.5%, both of which are strong relative to the industry median for personal products firms. The company's operating margin is 17.24% (calculated from operating income of ¥11.16 billion on revenue of ¥64.72 billion), which is in line with the industry's preferred profitability benchmarks. The gross margin of 66.87% (calculated from gross profit of ¥43.28 billion) reflects efficient cost management and pricing power in its core markets. Geographically, the company's revenue is concentrated in Japan, with no disclosed international segments. This concentration may expose the firm to regional economic fluctuations and regulatory changes, but it also allows for focused operational control and brand consistency. The company operates a single business segment, which simplifies its reporting and strategic focus. The company's revenue growth trajectory is stable, with a current fiscal year (FY) outlook indicating a modest increase in revenue. Analysts project a mean price target of ¥4,420, which is slightly above the current market price of ¥4,375, suggesting a neutral to slightly bullish sentiment. The company's free cash flow is negative at ¥1.15 billion, primarily due to capital expenditures of ¥2.52 billion, which may indicate ongoing investment in growth or operational efficiency. The risk assessment indicates low liquidity and dilution risks, with no immediate filing-based flags detected. The company's low debt levels and strong cash reserves reduce the likelihood of liquidity stress. Additionally, the absence of dilution risk suggests that the company is not currently issuing new shares to raise capital, preserving shareholder value. Recent events, including filings and transcripts, do not highlight any material changes in the company's operations or strategic direction. The company's financial performance and market position remain consistent with its historical trends, and there are no significant new risks or opportunities identified in the latest disclosures.

30-day price · 4928-205.00 (-4.5%)
Low$4190.00High$4595.00Close$4355.00As of22 May, 00:00 UTC
Profile
CompanyNoevir Holdings Co Ltd
Ticker4928.T
SectorConsumer Non-Cyclicals
BusinessPersonal & Household Products & Services
Industry groupPersonal & Household Products & Services
IndustryPersonal Products
AI analysis

Business. Noevir Holdings Co Ltd is a personal products company that generates revenue primarily through the sale of consumer goods in the personal care and household products sector.

Classification. The company is classified under the industry "Personal Products" within the business sector "Personal & Household Products & Services" in the economic sector "Consumer Non-Cyclicals," with a confidence level of 0.92.

The company maintains a strong liquidity position, with a current ratio of 4.96 and cash and equivalents amounting to ¥26.93 billion, which is significantly higher than the typical liquidity needs for a firm in the personal products industry. The debt-to-equity ratio is 0.01, indicating a conservative capital structure with minimal reliance on debt financing. This low leverage supports financial stability and flexibility in capital allocation. Profitability metrics show a return on equity (ROE) of 14.93% and a return on assets (ROA) of 10.5%, both of which are strong relative to the industry median for personal products firms. The company's operating margin is 17.24% (calculated from operating income of ¥11.16 billion on revenue of ¥64.72 billion), which is in line with the industry's preferred profitability benchmarks. The gross margin of 66.87% (calculated from gross profit of ¥43.28 billion) reflects efficient cost management and pricing power in its core markets. Geographically, the company's revenue is concentrated in Japan, with no disclosed international segments. This concentration may expose the firm to regional economic fluctuations and regulatory changes, but it also allows for focused operational control and brand consistency. The company operates a single business segment, which simplifies its reporting and strategic focus. The company's revenue growth trajectory is stable, with a current fiscal year (FY) outlook indicating a modest increase in revenue. Analysts project a mean price target of ¥4,420, which is slightly above the current market price of ¥4,375, suggesting a neutral to slightly bullish sentiment. The company's free cash flow is negative at ¥1.15 billion, primarily due to capital expenditures of ¥2.52 billion, which may indicate ongoing investment in growth or operational efficiency. The risk assessment indicates low liquidity and dilution risks, with no immediate filing-based flags detected. The company's low debt levels and strong cash reserves reduce the likelihood of liquidity stress. Additionally, the absence of dilution risk suggests that the company is not currently issuing new shares to raise capital, preserving shareholder value. Recent events, including filings and transcripts, do not highlight any material changes in the company's operations or strategic direction. The company's financial performance and market position remain consistent with its historical trends, and there are no significant new risks or opportunities identified in the latest disclosures.
Key takeaways
  • Noevir Holdings maintains a conservative capital structure with a low debt-to-equity ratio of 0.01 and strong liquidity.
  • The company's profitability metrics, including ROE of 14.93% and ROA of 10.5%, are robust and in line with industry benchmarks.
  • Revenue is concentrated in Japan, which may limit diversification but allows for focused operational control.
  • Analysts project a neutral to slightly bullish outlook, with a mean price target of ¥4,420.
  • The company faces low liquidity and dilution risks, with no immediate filing-based flags detected.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyJPY
Revenue$64.72B
Gross profit$43.28B
Operating income$11.16B
Net income$8.03B
R&D
SG&A
D&A
SBC
Operating cash flow$7.93B
CapEx-$2.52B
Free cash flow-$1.15B
Total assets$76.49B
Total liabilities$22.72B
Total equity$53.77B
Cash & equivalents$26.93B
Long-term debt$742.0M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$64.72B$11.16B$8.03B-$1.15B
FY-1$63.82B$11.42B$7.97B$566.0M
FY-2$62.55B$11.02B$7.67B$641.0M
FY-3$61.14B$10.77B$7.59B$1.33B
FY-4$51.27B$8.52B$6.38B$519.0M
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$76.49B$53.77B$26.93B
FY-1$76.47B$53.48B$29.22B
FY-2$77.25B$52.79B$28.88B
FY-3$76.78B$52.06B$29.75B
FY-4$80.45B$51.93B$31.10B
PeriodOCFCapExFCFSBC
FY0$7.93B-$2.52B-$1.15B
FY-1$9.12B-$1.01B$566.0M
FY-2$7.62B-$1.05B$641.0M
FY-3$5.85B-$613.0M$1.33B
FY-4$9.08B-$433.0M$519.0M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$15.15B$2.28B$1.40B
FQ-1$15.47B$1.97B$1.32B
FQ-2$17.44B$3.07B$3.90B$3.54B
FQ-3$15.25B$2.30B$1.48B$1.62B
FQ-4$15.23B$2.62B$1.67B$158.0M
FQ-5$16.80B$3.17B$974.0M-$6.47B
FQ-6$15.59B$2.41B$3.48B$3.48B
FQ-7$16.61B$2.85B$1.89B$1.83B
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$71.74B$48.86B$23.42B
FQ-1$70.43B$47.47B$12.49B
FQ-2$76.49B$53.77B$26.93B
FQ-3$73.36B$49.82B$15.47B
FQ-4$72.70B$48.32B$23.80B
FQ-5$71.02B$46.97B$13.28B
FQ-6$76.47B$53.48B$29.22B
FQ-7$75.44B$50.42B$28.31B
PeriodOCFCapExFCFSBC
FQ0$3.08B-$358.0M
FQ-1
FQ-2$7.93B-$2.52B$3.54B
FQ-3$5.81B-$1.92B$1.62B
FQ-4$3.99B-$1.80B$158.0M
FQ-5$1.55B-$90.0M-$6.47B
FQ-6$9.12B-$1.01B$3.48B
FQ-7$7.53B-$745.0M$1.83B
Valuation
Market price$4375.00
Market cap$149.43B
Enterprise value$123.25B
P/E18.6
Reported non-GAAP P/E
EV/Revenue1.9
EV/Op income11.0
EV/OCF15.6
P/B2.8
P/Tangible book2.8
Tangible book$53.77B
Net cash$26.19B
Current ratio5.0
Debt/Equity0.0
ROA10.5%
ROE14.9%
Cash conversion99.0%
CapEx/Revenue-3.9%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Personal Products · cohort 225 companies
Metric4928Activity
Op margin17.2%16.2% medp25 16.2% · p75 16.2%top quartile
Net margin12.4%10.5% medp25 10.5% · p75 10.5%top quartile
Gross margin66.9%60.1% medp25 60.1% · p75 60.1%top quartile
R&D / revenue1.8% medp25 1.8% · p75 1.8%
CapEx / revenue-3.9%-2.3% medp25 -4.4% · p75 -1.1%below median
Debt / equity1.0%12724.1% medp25 12724.1% · p75 12724.1%bottom quartile
Observations
IR observations
Mean price target4,420.00 JPY
Median price target4,420.00 JPY
High price target4,420.00 JPY
Low price target4,420.00 JPY
Mean recommendation3.00 (1=strong buy, 5=strong sell)
Strong-buy count0.00
Buy count0.00
Hold count1.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate240.10 JPY
Last actual EPS235.10 JPY
Source: analysis-pipeline (hybrid)Generated: 2026-05-25 00:20 UTCJob: 7374a08c